Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Fundamental Analysis

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock

21.33  +2.33 (+12.26%)

Premarket: 21.65 +0.32 (+1.5%)

Fundamental Rating

4

Overall SDGR gets a fundamental rating of 4 out of 10. We evaluated SDGR against 39 industry peers in the Health Care Technology industry. SDGR has a great financial health rating, but its profitability evaluates not so good. SDGR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SDGR had negative earnings in the past year.
In the past year SDGR has reported a negative cash flow from operations.
SDGR had negative earnings in 4 of the past 5 years.
SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

SDGR has a Return On Assets (-26.53%) which is in line with its industry peers.
SDGR's Return On Equity of -39.51% is in line compared to the rest of the industry. SDGR outperforms 59.46% of its industry peers.
Industry RankSector Rank
ROA -26.53%
ROE -39.51%
ROIC N/A
ROA(3y)-9.96%
ROA(5y)-9.8%
ROE(3y)-14.64%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

SDGR's Gross Margin of 64.91% is in line compared to the rest of the industry. SDGR outperforms 56.76% of its industry peers.
In the last couple of years the Gross Margin of SDGR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SDGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.4%
GM growth 5Y0.16%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SDGR has more shares outstanding
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

SDGR has an Altman-Z score of 3.06. This indicates that SDGR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SDGR (3.06) is better than 72.97% of its industry peers.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.06
ROIC/WACCN/A
WACC9.52%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.11 indicates that SDGR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.11, SDGR belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
SDGR has a Quick Ratio of 4.11. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.11, SDGR belongs to the top of the industry, outperforming 83.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.11
Quick Ratio 4.11
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

SDGR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -526.32%.
The Revenue has decreased by -3.03% in the past year.
SDGR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.61% yearly.
EPS 1Y (TTM)-526.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.53%
Revenue 1Y (TTM)-3.03%
Revenue growth 3Y26.08%
Revenue growth 5Y26.61%
Sales Q2Q%-17.1%

3.2 Future

The Earnings Per Share is expected to grow by 64.11% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.36% on average over the next years. This is quite good.
EPS Next Y-547.12%
EPS Next 2Y-157.5%
EPS Next 3Y-82.68%
EPS Next 5Y64.11%
Revenue Next Year-8.38%
Revenue Next 2Y7.66%
Revenue Next 3Y11.54%
Revenue Next 5Y15.36%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SDGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SDGR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as SDGR's earnings are expected to decrease with -82.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-157.5%
EPS Next 3Y-82.68%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SDGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHRODINGER INC

NASDAQ:SDGR (1/21/2025, 8:25:59 PM)

Premarket: 21.65 +0.32 (+1.5%)

21.33

+2.33 (+12.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners95.58%
Inst Owner Change0.03%
Ins Owners2.43%
Ins Owner Change-0.02%
Market Cap1.55B
Analysts81.18
Price Target32.64 (53.02%)
Short Float %15.38%
Short Ratio12.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.67%
Min EPS beat(2)14.46%
Max EPS beat(2)14.87%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-6.54%
Max EPS beat(4)14.87%
EPS beat(8)6
Avg EPS beat(8)22.21%
EPS beat(12)8
Avg EPS beat(12)15.42%
EPS beat(16)9
Avg EPS beat(16)7.6%
Revenue beat(2)1
Avg Revenue beat(2)1.61%
Min Revenue beat(2)-14.72%
Max Revenue beat(2)17.94%
Revenue beat(4)1
Avg Revenue beat(4)-4.82%
Min Revenue beat(4)-14.72%
Max Revenue beat(4)17.94%
Revenue beat(8)3
Avg Revenue beat(8)-0.33%
Revenue beat(12)7
Avg Revenue beat(12)6.85%
Revenue beat(16)8
Avg Revenue beat(16)4.12%
PT rev (1m)0%
PT rev (3m)-3.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.9%
EPS NY rev (1m)0%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.04
P/FCF N/A
P/OCF N/A
P/B 3.46
P/tB 3.5
EV/EBITDA N/A
EPS(TTM)-2.43
EYN/A
EPS(NY)-2.5
Fwd EYN/A
FCF(TTM)-2.37
FCFYN/A
OCF(TTM)-2.24
OCFYN/A
SpS2.65
BVpS6.17
TBVpS6.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.53%
ROE -39.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.91%
FCFM N/A
ROA(3y)-9.96%
ROA(5y)-9.8%
ROE(3y)-14.64%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.4%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.23%
Cap/Sales 4.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.11
Quick Ratio 4.11
Altman-Z 3.06
F-Score4
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)225.85%
Cap/Depr(5y)159.5%
Cap/Sales(3y)5.27%
Cap/Sales(5y)4.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-526.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.53%
EPS Next Y-547.12%
EPS Next 2Y-157.5%
EPS Next 3Y-82.68%
EPS Next 5Y64.11%
Revenue 1Y (TTM)-3.03%
Revenue growth 3Y26.08%
Revenue growth 5Y26.61%
Sales Q2Q%-17.1%
Revenue Next Year-8.38%
Revenue Next 2Y7.66%
Revenue Next 3Y11.54%
Revenue Next 5Y15.36%
EBIT growth 1Y-23.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-21.22%
EBIT Next 3Y3.4%
EBIT Next 5YN/A
FCF growth 1Y-41.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.83%
OCF growth 3YN/A
OCF growth 5YN/A